We are live on ! Find out more
ICP

Ironvine Capital Partners Portfolio holdings

AUM $910M
1-Year Est. Return 10.64%
This Fund
S&P 500
This Quarter Est. Return
+7.03%
1 Year Est. Return
+10.64%
3 Year Est. Return
+51.78%
5 Year Est. Return
+63.74%
10 Year Est. Return
AUM
$772M
AUM Growth
+$27.3M
Cap. Flow
-$13.9M
Cap. Flow %
-1.81%
Top 10 Hldgs %
51.12%
Holding
51
New
Increased
21
Reduced
11
Closed
2

Top Buys

Rank Stock Value
1
CTLT
CATALENT, INC.
CTLT
+$11.8M
2
V icon
Visa
V
+$2.36M
3
TMO icon
Thermo Fisher Scientific
TMO
+$2.13M
4
UNH icon
UnitedHealth
UNH
+$1.22M
5
JPM icon
JPMorgan Chase
JPM
+$978K

Sector Composition

Rank Sector Weight
1 Financials 32.13%
2 Technology 20.61%
3 Healthcare 15.8%
4 Consumer Staples 10.57%
5 Communication Services 5.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
META icon
51
Meta Platforms (Facebook)
META
$1.51T
-140,177
Closed -$19M

Similar funds

Ironvine Capital Partners's Q4 2022 Portfolio in Review

As of Q4 2022, Ironvine Capital Partners held 51 positions worth $772M, up 3.7% from $745M the previous quarter. Its ten largest holdings account for 51% of the portfolio.

Trading was light in Q4 2022: portfolio turnover was 3.9%. Ironvine Capital Partners opened no new positions and exited 2, leaving the 51-position portfolio largely intact.

By sector, the portfolio is most concentrated in Financials at 32% of assets, up from 30% a quarter earlier, followed by Technology and Healthcare.

  • Ironvine Capital Partners added most to CATALENT, INC. in Q4 2022, an estimated $11.8M increase.
  • Ironvine Capital Partners's biggest Q4 2022 reduction was Berkshire Hathaway Class B, cutting an estimated $9.53M.
  • Ironvine Capital Partners fully exited Meta Platforms (Facebook) in Q4 2022, selling an estimated $19M.
  • Ironvine Capital Partners's ten largest holdings make up 51% of its $772M portfolio in Q4 2022.
  • Ironvine Capital Partners opened 0 new positions and closed 2 in Q4 2022.
  • Ironvine Capital Partners's portfolio value rose 3.7% quarter-over-quarter to $772M.

Based on Ironvine Capital Partners's 13F filing for Q4 2022, filed 14 Feb 2023.